IE
KRRO icon

Israel Englander’s Korro Bio KRRO Stock Holding History

Israel Englander’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-300
Closed -$143K – 6813
2021
Q1 		$143K Buy
+300
New +$583K ﹤0.01% 5606

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Israel Englander's KRRO Position: Q2 2026 in Review

Israel Englander increased its Korro Bio (KRRO) stake by 86% in Q2 2026, buying an estimated $681K and bringing the position to 118,434 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #4002.

Israel Englander first reported a position in KRRO in Q4 2019 and has held it in 22 quarters since. The position peaked at $12.5M in Q3 2025. 106 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Israel Englander held 118,434 shares of Korro Bio worth $1.56M as of Q2 2026.
  • Israel Englander bought 54,828 Korro Bio shares in Q2 2026, an estimated $681K.
  • Korro Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4002 holding.
  • Israel Englander first reported a position in Korro Bio in Q4 2019 and has held it in 22 quarters since.
  • Israel Englander's Korro Bio position peaked at $12.5M in Q3 2025.
  • 106 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.